(CCLD) CareCloud - Overview

Sector: Healthcare | Industry: Health Information Services | Exchange: NASDAQ (USA) | Market Cap: 115m USD | Total Return: 109% in 12m

Healthcare IT, Practice Management, Revenue Cycle, Digital Health
Total Rating 56
Safety 22
Buy Signal -0.87
Health Information Services
Industry Rotation: -17.8
Market Cap: 115M
Avg Turnover: 2.07M USD
ATR: 8.24%
Peers RS (IBD): 77.3
Risk 5d forecast
Volatility89.8%
Rel. Tail Risk-20.8%
Reward TTM
Sharpe Ratio1.43
Alpha48.56
Character TTM
Beta2.252
Beta Downside3.563
Drawdowns 3y
Max DD79.41%
CAGR/Max DD-0.11
EPS (Earnings per Share) EPS (Earnings per Share) of CCLD over the last years for every Quarter: "2021-03": -0.36, "2021-06": -0.27, "2021-09": -0.15, "2021-12": -0.01, "2022-03": -0.19, "2022-06": -0.07, "2022-09": -0.18, "2022-12": -0.22, "2023-03": -0.28, "2023-06": -0.37, "2023-09": -0.42, "2023-12": -0.35, "2024-03": -0.02, "2024-06": -0.14, "2024-09": -0.0412, "2024-12": 0.23, "2025-03": -0.0362, "2025-06": 0.04, "2025-09": 0.04, "2025-12": 0.11, "2026-03": 0,
EPS CAGR: 4.82%
EPS Trend: 64.8%
Last SUE: 0.17
Qual. Beats: 0
Revenue Revenue of CCLD over the last years for every Quarter: 2021-03: 29.768, 2021-06: 34.065, 2021-09: 38.304, 2021-12: 37.462, 2022-03: 35.341, 2022-06: 37.228, 2022-09: 33.723, 2022-12: 32.534, 2023-03: 30.001, 2023-06: 29.362, 2023-09: 29.28, 2023-12: 28.416, 2024-03: 25.962, 2024-06: 28.09, 2024-09: 28.546, 2024-12: 28.239, 2025-03: 27.632, 2025-06: 27.377, 2025-09: 31.067, 2025-12: 34.423, 2026-03: null,
Rev. CAGR: -0.70%
Rev. Trend: -48.8%
Last SUE: 1.93
Qual. Beats: 2

Warnings

Share dilution 137.5% YoY - potential capital distress

Altman Z'' -3.24 < 1.0 - financial distress zone

Volatile

Tailwinds

No distinct edge detected

Description: CCLD CareCloud

CareCloud, Inc. (CCLD) is a U.S.-based healthcare information technology company. It offers technology solutions and business services to healthcare providers and hospitals, operating through Healthcare IT and Medical Practice Management segments.

The companys offerings include proprietary software, cloud-based solutions, digital health services, and IT professional services. A key aspect of its business model involves revenue cycle management, a critical function for healthcare providers to optimize financial performance. It also provides electronic health records (EHR), which are foundational to modern healthcare operations and interoperability.

CareCloud further develops artificial intelligence (AI) tools, such as CareCloud cirrusAI, for clinical decision support and administrative automation. The healthcare IT sector is experiencing rapid innovation, particularly in AI-driven solutions to improve efficiency and patient outcomes. Additionally, the company provides chronic care management, remote patient monitoring, and telemedicine solutions, reflecting the growing trend towards virtual care delivery.

CareCloud serves a broad range of clinicians, including physicians, nurses, and therapists. The company also offers comprehensive medical practice management services, encompassing facilities, equipment, staffing, and financial advisory. To learn more about CareClouds financial health and market position, consider exploring its detailed profile on ValueRay.

Headlines to Watch Out For
  • Healthcare IT solutions adoption drives revenue growth
  • Medical practice management services impact profitability
  • Regulatory changes affect healthcare technology demand
  • AI integration expands product offerings and market share
Piotroski VR‑10 (Strict) 7.0
Net Income: 10.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.33 > 0.02 and ΔFCF/TA 10.40 > 1.0
NWC/Revenue: 1.09% < 20% (prev 4.71%; Δ -3.62% < -1%)
CFO/TA 0.33 > 3% & CFO 28.6m > Net Income 10.8m
Net Debt (1.17m) to EBITDA (28.2m): 0.04 < 3
Current Ratio: 1.05 > 1.5 & < 3
Outstanding Shares: last quarter (379.5m) vs 12m ago 2.24k% < -2%
Gross Margin: 34.09% > 18% (prev 0.45%; Δ 3.36k% > 0.5%)
Asset Turnover: 151.4% > 50% (prev 154.8%; Δ -3.40% > 0%)
Interest Coverage Ratio: 40.06 > 6 (EBITDA TTM 28.2m / Interest Expense TTM 287k)
Altman Z'' -3.24
A: 0.02 (Total Current Assets 25.7m - Total Current Liabilities 24.4m) / Total Assets 87.6m
B: -0.64 (Retained Earnings -55.8m / Total Assets 87.6m)
C: 0.14 (EBIT TTM 11.5m / Avg Total Assets 79.6m)
D: -2.13 (Book Value of Equity -59.8m / Total Liabilities 28.1m)
Altman-Z'' Score: -3.24 = D
Beneish M -2.82
DSRI: 1.01 (Receivables 18.7m/17.1m, Revenue 120.5m/110.8m)
GMI: 1.32 (GM 34.09% / 45.11%)
AQI: 1.09 (AQ_t 0.58 / AQ_t-1 0.54)
SGI: 1.09 (Revenue 120.5m / 110.8m)
TATA: -0.20 (NI 10.8m - CFO 28.6m) / TA 87.6m)
Beneish M-Score: -2.82 (Cap -4..+1) = A
What is the price of CCLD shares? As of April 14, 2026, the stock is trading at USD 2.80 with a total of 582,110 shares traded.
Over the past week, the price has changed by -13.58%, over one month by -10.83%, over three months by -4.44% and over the past year by +108.96%.
Is CCLD a buy, sell or hold? CareCloud has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold CCLD.
  • StrongBuy: 0
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the CCLD price?
Analysts Target Price 6.3 125.4%
CareCloud (CCLD) - Fundamental Data Overview as of 12 April 2026
P/E Trailing = 27.0
P/E Forward = 9.0992
P/S = 0.9521
P/B = 2.5058
P/EG = 0.3137
Revenue TTM = 120.5m USD
EBIT TTM = 11.5m USD
EBITDA TTM = 28.2m USD
Long Term Debt = 441k USD (from longTermDebt, last quarter)
Short Term Debt = 1.66m USD (from shortTermDebt, last quarter)
Debt = 4.28m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.17m USD (from netDebt column, last quarter)
Enterprise Value = 115.9m USD (114.7m + Debt 4.28m - CCE 3.12m)
Interest Coverage Ratio = 40.06 (Ebit TTM 11.5m / Interest Expense TTM 287k)
EV/FCF = 4.06x (Enterprise Value 115.9m / FCF TTM 28.6m)
FCF Yield = 24.64% (FCF TTM 28.6m / Enterprise Value 115.9m)
FCF Margin = 23.70% (FCF TTM 28.6m / Revenue TTM 120.5m)
Net Margin = 8.96% (Net Income TTM 10.8m / Revenue TTM 120.5m)
Gross Margin = 34.09% ((Revenue TTM 120.5m - Cost of Revenue TTM 79.4m) / Revenue TTM)
Gross Margin QoQ = 3.41% (prev 47.78%)
Tobins Q-Ratio = 1.32 (Enterprise Value 115.9m / Total Assets 87.6m)
Interest Expense / Debt = 0.33% (Interest Expense 14.0k / Debt 4.28m)
Taxrate = 2.47% (73.0k / 2.96m)
NOPAT = 11.2m (EBIT 11.5m * (1 - 2.47%))
Current Ratio = 1.05 (Total Current Assets 25.7m / Total Current Liabilities 24.4m)
Debt / Equity = 0.07 (Debt 4.28m / totalStockholderEquity, last quarter 59.5m)
Debt / EBITDA = 0.04 (Net Debt 1.17m / EBITDA 28.2m)
Debt / FCF = 0.04 (Net Debt 1.17m / FCF TTM 28.6m)
Total Stockholder Equity = 56.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.56% (Net Income 10.8m / Total Assets 87.6m)
RoE = 18.98% (Net Income TTM 10.8m / Total Stockholder Equity 56.9m)
RoCE = 20.05% (EBIT 11.5m / Capital Employed (Equity 56.9m + L.T.Debt 441k))
RoIC = 19.00% (NOPAT 11.2m / Invested Capital 59.0m)
WACC = 13.41% (E(114.7m)/V(119.0m) * Re(13.90%) + D(4.28m)/V(119.0m) * Rd(0.33%) * (1-Tc(0.02)))
Discount Rate = 13.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 54.11%
[DCF] Terminal Value 65.94% ; FCFF base≈23.5m ; Y1≈29.0m ; Y5≈49.5m
[DCF] Fair Price = 9.28 (EV 395.5m - Net Debt 1.17m = Equity 394.3m / Shares 42.5m; r=13.41% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 64.78 | EPS CAGR: 4.82% | SUE: 0.17 | # QB: 0
Revenue Correlation: -48.84 | Revenue CAGR: -0.70% | SUE: 1.93 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.05 | Chg7d=+0.013 | Chg30d=+0.013 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.37 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=+1 | Growth EPS=+8.8% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=0.28 | Chg7d=+0.085 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=+44.7% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.2% (Discount Rate 13.9% - Earnings Yield 3.7%)
[Growth] Growth Spread = +10.1% (Analyst 20.2% - Implied 10.2%)
External Resources
Dataroma Stockcircle